THE BOB MACKAY MEMORIAL ENDOWMENT FUND
The Bob MacKay Memorial Endowment Fund supports the research and educational activities of the Blood and Marrow Transplant (BMT) Program at Wake Forest University. Over the years, the Fund has provided needed funds in several areas:
The Fund has also been an integral component of our ability to compete for funds from the pharmaceutical industry and to participate in the multi-center clinical trials sponsored by the pharmaceutical industry. Through this effort, improved means of treating and supporting the transplant patient have been developed that have become the new standards for patient management.
With the support of the Fund, the Wake Forest University Baptist Medical Center was the first BMT Program in North Carolina to become accredited by the Foundation for Accreditation of Cellular Therapy (FACT). Accreditation by FACT is now recognized as the gold standard for approval of transplant programs in North America. The Transplant Program has been continuously FACT accredited, undergoing a review and re-accreditation every 3 years. The program and has recently been recognized to be among a select group of centers for its ongoing accreditation by FACT.
As a result of all the activities supported by the Fund, the Faculty, Fellows, Residents, and Students involved in BMT research, there have been over 60 articles and book chapters published, over 100 abstracts published, and over 75 presentations at meetings and educational symposia.
It can be stated with certainty that the Bob MacKay Memorial Endowment Fund has been integral to the mission of the Blood and Marrow Transplant Program at Wake Forest University. We would not have been able to do what has been done to improve the care of our patients and the outcomes of transplants without its support.
David D. Hurd, M.D.